Seeking Alpha

Gilead (GILD) plans to move forward with the sale of generic versions of four HIV treatments in...

Gilead (GILD) plans to move forward with the sale of generic versions of four HIV treatments in developing countries under the terms of an agreement with a UN-backed patent foundation. New studies show the firm's Truvada HIV pill can prevent the virus transmission, after an early study said the opposite.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs